In contrast, knockdown of heparanase or treatments of tumor-bearing mice with heparanase-inhibiting compounds markedly attenuate tumor progression, further underscoring the potential of anti-heparanase therapy for multiple types of cancer. This evidence concerns the gene HPSE and neoplasm.